GLP-1 medications
GLP-1 is a hormone your gut releases after you eat — it tells your brain you're full and helps your body manage blood sugar. GLP-1 medications (semaglutide, tirzepatide, and newer molecules) copy that signal, which is why they're so widely studied for weight management and metabolic health.
The articles below explain how these medications work, what the research actually shows, and what side effects and dosing schedules look like in practice. Promise offers compounded GLP-1 medications by prescription only: a licensed provider reviews every request, and not everyone qualifies.
250 articles on this topic
-
Does Semaglutide Cause Dizziness? What Labels Say
Yes, dizziness can happen. The Wegovy and Ozempic labels give different levels of detail; fluid loss, blood sugar, and blood pressure help explain what a provider checks.
-
Compounded Semaglutide China Alert: What It Means Now
Recent compounded semaglutide China reports trace back to two raw-ingredient factories placed on an FDA border-hold list. Here is what the alert covers, how U.S. pharmacy sourcing rules work, and what patients can ask.
-
GLP-1 Schizophrenia Study: What the Hospital Data Means
An October 2026 U.S. study linked starting a GLP-1 drug in adults with schizophrenia and type 2 diabetes to a lower psychiatric hospitalization hazard. These drugs are not FDA-approved for schizophrenia, and health records cannot prove cause and effect.
-
GLP-1 Vision Loss Study: Small Added Eye Risk Explained
October headlines revisited a 2026 diabetes study finding 3 to 4 extra coded optic-nerve cases per 10,000 people over 18 months. Here is what those numbers mean, how U.S. and European guidance differ, and why sudden vision loss needs immediate care.
-
Tirzepatide Telehealth Study: 15.5% Loss at Six Months
A large UK digital program tracked 8,127 women starting treatment, almost all on tirzepatide. Women with six-month weigh-ins lost an average of 15.5% of their starting weight, though study limits matter.
-
Relative Risk vs Absolute Risk: Numbers Explained
Relative risk compares two groups. Absolute risk shows how often an event happened. SELECT and a gallbladder warning show why both numbers matter.
-
Does Tirzepatide Cause Headaches? What Trials Show
Headaches occurred in about 7 in 100 people in SURMOUNT-1, with similar rates on placebo. Fluid loss, missed meals, and other medicines can still matter.
-
Semaglutide and Smoking: Can It Help You Quit?
Early studies have found lower cigarette cravings, but semaglutide hasn't been established as a quitting treatment. The difference matters when reading the headlines.
-
Semaglutide and Cholesterol: What Changes?
Semaglutide trials found small cholesterol changes and a larger drop in triglycerides, another blood fat. Those results don’t replace prescribed cholesterol treatment.
-
Semaglutide and Testosterone: What Studies Show
Low testosterone may rise as men with obesity lose weight on semaglutide. Small studies support that link, but a direct hormone effect remains unproven.
-
Does Tirzepatide Cause Acid Reflux? It Can
Tirzepatide can cause reflux and indigestion. The brand labels show how often each was reported, while persistent or severe symptoms need a clinician's review.
-
Feeling Cold on Tirzepatide: An Autumn Guide
Feeling chilly can accompany weight loss, but persistent coldness deserves a closer look. Here's what the labels say and what cold weather means for storage.
-
Ozempic Face: What Facial Changes Really Mean
Ozempic face means a face looking less full after weight loss. Small studies document changes, but they cannot settle whether the drug has a direct effect.
-
STRIDE Trial Semaglutide: Walking Results
Semaglutide was associated with better treadmill walking in people with leg artery disease and type 2 diabetes. Here are the numbers, side effects and limits of STRIDE.
-
STEP 5 Trial Results: Semaglutide at Two Years
In STEP 5, average weight loss was 15.2% with semaglutide versus 2.6% with placebo at two years. The plateau, side effects and two calculations explain what held up.
-
What Is Dose Titration? Why Doses Change in Steps
Dose titration means changing a dose in steps while checking response and side effects. A gradual climb has a purpose, and the highest dose isn’t everyone’s destination.
-
Semaglutide and Gout: It Isn't a Gout Treatment
Semaglutide may lower uric acid, but fewer gout attacks remain unproven. New findings make a gout history and a flare plan part of the prescribing conversation.
-
Semaglutide Knee Osteoarthritis: What STEP 9 Found
In STEP 9, adults with obesity had greater average knee-pain and weight reductions with semaglutide. The trial did not establish cartilage repair.
-
What Is Food Noise? Meaning and GLP-1 Evidence
Food noise means intrusive food thoughts that are hard to set aside. GLP-1 studies offer evidence about cravings and eating control, while the term itself is still being defined.
-
Zenagamtide: Amycretin’s New Name, Still in Trials
Zenagamtide is amycretin’s new name: an experimental drug being tested as a weekly shot and a daily pill. Here’s what the trials actually found.
Page 1 of 13 · 250 articles